Detalhe da pesquisa
1.
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.
Nature
; 571(7764): 265-269, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207605
2.
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
Haematologica
; 108(7): 1827-1839, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200421
3.
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
Lancet
; 398(10316): 2093-2100, 2021 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756184
4.
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma.
Haematologica
; 107(10): 2395-2407, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35354252
5.
Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation.
Nanomedicine
; 46: 102596, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36031044
6.
Targeting glycosylated antigens on cancer cells using siglec-7/9-based CAR T-cells.
Mol Carcinog
; 59(7): 713-723, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32391973
7.
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System.
Mol Ther
; 24(6): 1078-1089, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945006
8.
Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activity.
J Immunol
; 191(8): 4121-9, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24026081
9.
Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity.
J Immunol
; 188(11): 5538-46, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22544927
10.
Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.
J Immunol
; 188(4): 1708-16, 2012 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22250090
11.
Genetically modulating T-cell function to target cancer.
Semin Cancer Biol
; 22(1): 14-22, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22210183
12.
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma.
Blood Adv
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768428
13.
Enhanced antitumor activity mediated by human 4-1BB-engineered T cells.
Int J Cancer
; 133(12): 2903-13, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23754772
14.
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
Cancer Immunol Immunother
; 61(10): 1833-47, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22441657
15.
Selected murine residues endow human TCR with enhanced tumor recognition.
J Immunol
; 184(11): 6232-41, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20427762
16.
Adoptive T-cell Immunotherapy: Perfecting Self-Defenses.
Exp Suppl
; 113: 253-294, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35165867
17.
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis.
Clin Cancer Res
; 28(23): 5156-5166, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36107221
18.
Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles.
ACS Omega
; 6(43): 28507-28514, 2021 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34746546
19.
A novel role for an old target: CD45 for breast cancer immunotherapy.
Oncoimmunology
; 10(1): 1929725, 2021 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34104545
20.
Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide.
Front Med (Lausanne)
; 8: 675963, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414199